Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Jon C. Ogg | Aug 12, 2015 at 7:35 AM EDT

5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains

It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding…

Jon C. Ogg | Aug 11, 2015 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Google, PDC Energy, Rackspace, XL Group and Many More

Tuesday's top analyst upgrades, downgrades and initiations include Adobe, Biogen, Google, PDC Energy, Rackspace and XL Group.

Lee Jackson | Aug 10, 2015 at 8:20 AM EDT

3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming

Merrill Lynch has looked at large cap biotech leaders and how interest rate increases may play a part in stock…

Jon C. Ogg | Aug 4, 2015 at 3:44 PM EDT

Will Biogen Win From Novartis MS Drug Safety Label Change?

ThinkstockThere are times when a negative piece of news in the BioPharma sector can actually help rival companies. Biogen Inc.…

Lee Jackson | Aug 4, 2015 at 8:35 AM EDT

3 Potential Huge Takeover Targets in Biotech

In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech…

Lee Jackson | Aug 1, 2015 at 9:05 AM EDT

Tech and Biotech See Big-Time Insider Buying This Week – Apple, Biogen, Qualcomm and More

ThinkstockNothing like earnings season coming around to buy stock if you are an insider and your company happens to disappoint.…

Jon C. Ogg | Jul 27, 2015 at 8:24 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, Chesapeake, Facebook, Qualcomm, Weatherford and Many More

Jon OggStocks were indicated lower by almost 1% on Monday after China’s Shanghai market suffered its biggest loss in about…

Chris Lange | Jul 27, 2015 at 7:57 AM EDT

Short Sellers Back Off Major Biotechs

ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of…

Jon C. Ogg | Jul 26, 2015 at 10:21 AM EDT

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings…

Paul Ausick | Jul 24, 2015 at 8:25 AM EDT

Why Biogen Shares Are Tumbling After Earnings Report

Biogen reported mixed second-quarter 2015 results before markets opened Friday morning.

Chris Lange | Jul 23, 2015 at 1:55 PM EDT

What to Look for in Biogen Earnings Report

Biogen is scheduled to release its second-quarter financial results before the markets open on Friday.

Jon C. Ogg | Jul 22, 2015 at 1:55 PM EDT

Biogen Faces Mixed Alzheimer’s Reception

It seems Biogen's closely watched Alzheimer's drug candidate, aducanumab, has fallen short of analyst and investor expectations.

Paul Ausick | Jul 20, 2015 at 9:35 AM EDT

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been…

Chris Lange | Jul 14, 2015 at 10:50 AM EDT

Why Biogen Is Now a Buy on Weakness

Merrill Lynch sees Biogen returning to these heightened levels, with its pipeline acting as the primary catalyst.

Jon C. Ogg | Jul 14, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, Biogen, GoPro, Intel, Micron, SunPower and More

Tuesday's top analyst upgrades, downgrades and initiations include Amazon.com, Biogen, GoPro, Intel, Micron Technology and SunPower.

1 … 22 23 24 25 26 … 41

Biogen : BIIB

All Biogen Articles

5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Google, PDC Energy, Rackspace, XL Group and Many More

3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming

Will Biogen Win From Novartis MS Drug Safety Label Change?

3 Potential Huge Takeover Targets in Biotech

Tech and Biotech See Big-Time Insider Buying This Week – Apple, Biogen, Qualcomm and More

Top Analyst Upgrades and Downgrades: AT&T, Chesapeake, Facebook, Qualcomm, Weatherford and Many More

Short Sellers Back Off Major Biotechs

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Why Biogen Shares Are Tumbling After Earnings Report

What to Look for in Biogen Earnings Report

Biogen Faces Mixed Alzheimer’s Reception

Top Health Care Earnings for the Week Ahead

Why Biogen Is Now a Buy on Weakness

Top Analyst Upgrades and Downgrades: Amazon, Biogen, GoPro, Intel, Micron, SunPower and More

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Biogen : BIIB

All Biogen Articles

5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Google, PDC Energy, Rackspace, XL Group and Many More

3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming

Will Biogen Win From Novartis MS Drug Safety Label Change?

3 Potential Huge Takeover Targets in Biotech

Tech and Biotech See Big-Time Insider Buying This Week – Apple, Biogen, Qualcomm and More

Top Analyst Upgrades and Downgrades: AT&T, Chesapeake, Facebook, Qualcomm, Weatherford and Many More

Short Sellers Back Off Major Biotechs

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Why Biogen Shares Are Tumbling After Earnings Report

What to Look for in Biogen Earnings Report

Biogen Faces Mixed Alzheimer’s Reception

Top Health Care Earnings for the Week Ahead

Why Biogen Is Now a Buy on Weakness

Top Analyst Upgrades and Downgrades: Amazon, Biogen, GoPro, Intel, Micron, SunPower and More

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%